Evidence map›Paper›PMID 32025476›Full record

ArticlePreventive medicine reports2020

Evaluation of a multimedia marketing campaign to engage African American patients in glaucoma screening.

Ava Kikut, Marquis Vaughn, Rebecca Salowe, Mohima Sanyal, Sayaka Merriam, Roy Lee, Emily Becker, Sara Lomax-Reese, Monica Lewis, Robert Ryan and 7 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Preventive medicine reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Ava KikutScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.
Marquis VaughnScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.
Rebecca SaloweScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.
Mohima SanyalScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.
Sayaka MerriamScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.
Roy LeeScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.
Emily BeckerScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.
Sara Lomax-ReeseWURD Radio, Philadelphia, PA, USA.
Monica LewisWURD Radio, Philadelphia, PA, USA.
Robert RyanTrialX, New York, NY, USA.
Ahmara RossScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.
Qi N CuiScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.
Victoria AddisScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.
Prithvi S SankarScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.
Eydie Miller-EllisScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.
Carolyn CannuscioDepartment of Family Medicine and Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Joan O'BrienScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.
University of Pennsylvania · USPenn Presbyterian Medical Center · US

Funding

Scientific TransparencyP30EY001583 · NEI · UNIVERSITY OF PENNSYLVANIA · PI CLAIRE H MITCHELL · 1985 to 2026
$19.5M
Primary Open Angle African-American Glaucoma Genetics Study RenewalR01EY023557 · NEI · UNIVERSITY OF PENNSYLVANIA · PI O'BRIEN, JOAN M · 2014 to 2025
$18.1M
The Development of Gene Therapy Using SIRT1 Signaling to Treat Chronic GlaucomaK08EY030163 · NEI · UNIVERSITY OF PENNSYLVANIA · PI ROSS, AHMARA G. · 2019 to 2022
$958k
Mitochondrial Respiratory Chain Dysfunction in Primary Open Angle GlaucomaK08EY029765 · NEI · UNIVERSITY OF PENNSYLVANIA · PI CUI, QI N · 2019 to 2021
$731k
NEI NIH HHS K08 EY029765NEI NIH HHS K08 EY030163NEI NIH HHS L30 EY029353NEI NIH HHS P30 EY001583NEI NIH HHS R01 EY023557
6 · The paper itself

Abstract

Our objective was to determine which messaging approaches from a marketing campaign were most effective in recruiting African American individuals to a glaucoma screening and research study. We conducted a multimedia marketing campaign in Philadelphia from 01/31/2018 to 06/30/2018. Messaging approaches included radio advertisements and interviews (conducted in partnership with a local radio station with a large African American listener base), print materials, event tables, and online postings. Participants received free glaucoma screenings and the opportunity to enroll in our glaucoma genetics study. These screenings allowed individuals with glaucoma to receive a full examination and treatment plan with a glaucoma specialist, as well as to contribute to future efforts to identify genetic variants underlying this disease. We compared inquiry, enrollment, and cost yield for each messaging approach. Our campaign resulted in 154 unique inquiries, with 98 patients receiving glaucoma screenings (64%) and 60 patients enrolling in our study (39%). Commercials on WURD radio yielded the highest number of inquiries (62%) and enrollments (62%), but at relatively high cost ($814/enrolled patient). The most inexpensive approach that yielded more than five enrollments was postcards ($429/enrolled patient). Our campaign suggests that high-frequency commercials and postcards distributed at targeted healthcare locations are particularly effective and affordable options for connecting with the African American community. Our findings can help to inform recruitment efforts for other understudied diseases in minority populations.

Indexed as

African AmericansBlindnessGlaucomaMarketing campaignMinority populationsOphthalmologyScreenings

Identifiers

PMID32025476
PMCPMC6997297
OpenAlexW3001807351

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.